Concepedia
Statistics
Publications
17
Citations
1.3K
H-Index
Active since
1992
Affiliations
University of Wisconsin–Madison(Current)
Abbott Fund
Abbott (United States)
AbbVie (United States)
Alex R. Shoemaker is an author at University of Wisconsin–Madison specializing in oncology, medicine, and pharmacology.
Publications per year
1992–2022
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes et al. · Clinical Cancer Research · 2008 · 209 citations
Medicine, Oncology, Pharmacology +12
Homozygosity for the <i>Min</i>allele of <i>Apc</i> results in disruption of mouse development prior to gastrulation
Amy Moser, Alex R. Shoemaker, Camille S. Connelly et al. · Developmental Dynamics · 1995 · 161 citations · Full text
Life Sciences, Developmental Biology, Genetics +13
A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs <i>In vitro</i> and <i>In vivo</i>
Alex R. Shoemaker, Anatol Oleksijew, Joy Bauch et al. · Cancer Research · 2006 · 146 citations
Medicine, Oncology, Pharmacology +10
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
Kenneth D. Bromberg, Taylor R. H. Mitchell, Anup K. Upadhyay et al. · Nature Chemical Biology · 2017 · 130 citations · Full text
Life Sciences, Genetics, Molecular Biology +11
Expression of Retinoic Acid Nuclear Receptors and Tissue Transglutaminase Is Altered in Various Tissues of Rats Fed a Vitamin A-Deficient Diet
Ajit Kumar Verma, Alex R. Shoemaker, Ruby Simsiman et al. · Journal of Nutrition · 1992 · 78 citations
Life Sciences, Biochemistry, Nutritional Sciences +16
1–5 of 17